Public trial registry of the CCC-Munich

Trial SWITCH-II

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
SWITCH-II
World
Full title
:

Phase III Randomized Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma

World
NCT number
:
World
Responsible organization
:
Urologie MRI Ismaninger Str.22 81675 München Germany
Indications
Classification Code Description
- Other Urological tumors
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Jürgen Gschwend Urologie MRI Ismaninger Str.22 81675 München Germany Magnifier